Fleece
BiologicalFibrin Patch
NCT Number: NCT00598130
This is a prospective, randomized, single blind, standard care- controlled study, which will include a total of 30 patients divided into two treatment arms: First are: patents who will be treated in accordance with standard of care. Second arm: patients for which the Fibrin Fleece will be applied directly on the active bleeding site.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Phase 2
Bnei-Zion MC, Haifa, Israel
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Fibrin Patch
Time frame: 10 minutes
Time frame: 5 minutes
OMRIX Biopharmaceuticals
Industry
A Prospective, Randomized, Single-Blind, Standard Care Controlled, Multi-Center, Phase II Study Evaluating the Safety and Hemostatic Efficacy of Fibrin Fleece in Partial Nephrectomy
Acronym: Fleece
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06664788
Hemostasis, Hemostatic Techniques
Los Angeles, California, United States
View Trial DetailsNCT06119568
Nephrectomy, Prostatectomy
Barcelona, Spain
View Trial DetailsNCT07527637
Endocrine System Diseases, Female Urogenital Diseases
View Trial DetailsNCT06849271
Nephrectomy, Prostatectomy
Barcelona, Spain
View Trial Details